This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1997 Dec:40 Suppl A:99-101.

doi: 10.1093/jac/40.suppl_1.99.

Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?

S R Norrby¹

Affiliations

PMID: 9484879
DOI: 10.1093/jac/40.suppl_1.99

Review

Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?

S R Norrby. J Antimicrob Chemother. 1997 Dec.

. 1997 Dec:40 Suppl A:99-101.

doi: 10.1093/jac/40.suppl_1.99.

Author

S R Norrby¹

Affiliation

¹ Department of Infectious Diseases, University of Lund, Lund University Hospital, Sweden.

PMID: 9484879
DOI: 10.1093/jac/40.suppl_1.99

No abstract available

PubMed Disclaimer

Similar articles

[Grepafloxacin (Vaxar)--innovative antibiotic for therapy of respiratory tract infections. Symposium: "Grepafloxacin--a new quinolone designed for respiratory tract infection. Lausanne/Switzerland, 25 May 1997].
[No authors listed] [No authors listed] Pneumologie. 1997 Sep;51(9 Suppl):1-4. Pneumologie. 1997. PMID: 9417540 German. No abstract available.
The activity of grepafloxacin against respiratory pathogens in the UK.
Wise R, Andrews JM. Wise R, et al. J Antimicrob Chemother. 1997 Dec;40 Suppl A:27-30. doi: 10.1093/jac/40.suppl_1.27. J Antimicrob Chemother. 1997. PMID: 9484870
Grepafloxacin--focus on respiratory infections.
Geddes AM. Geddes AM. J Antimicrob Chemother. 1997 Dec;40 Suppl A:1-4. doi: 10.1093/jac/40.suppl_1.1. J Antimicrob Chemother. 1997. PMID: 9484866 Review. No abstract available.
Antibacterial activity of grepafloxacin.
Wiedemann B, Heisig P. Wiedemann B, et al. J Antimicrob Chemother. 1997 Dec;40 Suppl A:19-25. doi: 10.1093/jac/40.suppl_1.19. J Antimicrob Chemother. 1997. PMID: 9484869 Review.
Study of the effects of AM-1155 in a rat chronic respiratory tract infection model with Pseudomonas aeruginosa.
Sato A, Kitazawa H, Chida K, Hayakawa H, Iwata M. Sato A, et al. Drugs. 1995;49 Suppl 2:253-5. doi: 10.2165/00003495-199500492-00059. Drugs. 1995. PMID: 8549321 No abstract available.

See all similar articles

Cited by

The next generation: fluoroquinolones in the management of acute lower respiratory infection in adults.
Moss PJ, Finch RG. Moss PJ, et al. Thorax. 2000 Jan;55(1):83-5. doi: 10.1136/thorax.55.1.83. Thorax. 2000. PMID: 10607807 Free PMC article. Review. No abstract available.
Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
Coyle EA, Kaatz GW, Rybak MJ. Coyle EA, et al. Antimicrob Agents Chemother. 2001 Jun;45(6):1654-9. doi: 10.1128/AAC.45.6.1654-1659.2001. Antimicrob Agents Chemother. 2001. PMID: 11353608 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information